CLINICAL ROLE -
Utilization Impacts of New Oral Substitutes for Parenteral Cancer-Related Therapies
Examination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.
Read More